Dentists in Melrose, MN Accepting Medicare
4 Dentists found. Showing 1 - 4
 Dr. Matthew P Ford, DMD Dentist Medicare: Medicare Enrolled Practice Location: 203 E Main St, Melrose, MN 56352 Phone: 320-256-4267 |
Ernest Allen Hedglin, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 615 West Main Street, Melrose, MN 56352 Phone: 320-256-4267 Fax: 320-256-4167 |
Chase Thomas Baumgartner, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 203 E Main St, Melrose, MN 56352 Phone: 320-256-4267 |
Russell Roman Sieben, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 615 West Main Street, Melrose, MN 56352 Phone: 320-256-4267 Fax: 320-256-4167 |
News Archive
Fixed-dose combination of sacubitril and valsartan for heart failure shows differing added benefit
The fixed-dose combination of sacubitril and valsartan (trade name: Entresto) has been approved since November 2015 for adults with symptomatic chronic heart failure with reduced pump function.
Anadys second-quarter net loss decreases to $3.0 million
Anadys Pharmaceuticals, Inc., a biopharmaceutical company dedicated to improving patient care by developing novel medicines for the treatment of hepatitis C, today reported its financial results and program highlights for the second quarter ended June 30, 2010.
Health Canada clears Zargis Cardioscan device for sale in Canada
Zargis Medical Corp., a majority-owned subsidiary of Speedus Corp. (Nasdaq: SPDE), today announced that Health Canada, the Canadian equivalent of the U.S. FDA, has cleared the Zargis Cardioscan(TM) device for sale in Canada.
Cipla, DNDi to develop ARV combination therapy for children with HIV/AIDS
On the eve of the XIX International AIDS Conference in Washington, DC, the Drugs for Neglected Diseases initiative (DNDi), a not-for-profit research and development (R&D) organization, announces a new collaboration with Indian drug manufacturer Cipla to develop and produce an improved first-line antiretroviral (ARV) combination therapy specifically adapted to meet the treatment needs of infants and toddlers living with HIV/AIDS.
POWER study results support the need to re-evaluate depression treatment in Ontario
Less than half of men and women in Ontario who may be suffering from depression see a doctor to treat their potentially debilitating condition, according to a new women's health study by researchers at St. Michael's Hospital and the Institute for Clinical Evaluative Sciences (ICES). What's more, many hospitalized for severe depression fail to see a doctor for follow-up care within 30 days of being discharged, and many head to hospital emergency departments for care.
› Verified 2 days ago